These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34607401)

  • 21. Trajectory of individual immunity and vaccination required for SARS-CoV-2 community immunity: a conceptual investigation.
    Saad-Roy CM; Levin SA; Metcalf CJE; Grenfell BT
    J R Soc Interface; 2021 Feb; 18(175):20200683. PubMed ID: 33530857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2.
    Sanz-Leon P; Hamilton LHW; Raison SJ; Pan AJX; Stevenson NJ; Stuart RM; Abeysuriya RG; Kerr CC; Lambert SB; Roberts JA
    Philos Trans A Math Phys Eng Sci; 2022 Oct; 380(2233):20210311. PubMed ID: 35965469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination Is the Only Acceptable Path to Herd Immunity.
    Rasmussen AL
    Med; 2020 Dec; 1(1):21-23. PubMed ID: 33521750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. R
    Elsaid M; Nasef MA; Huy NT
    Hum Vaccin Immunother; 2021 Nov; 17(11):3850-3854. PubMed ID: 34612165
    [No Abstract]   [Full Text] [Related]  

  • 25. The Effect of Governmental Health Measures on Public Behaviour During the COVID-19 Pandemic Outbreak.
    Wang G; Li L; Wang L; Xu Z
    Int J Health Policy Manag; 2022 Oct; 11(10):2166-2174. PubMed ID: 34814663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming COVID-19 in West African countries: is herd immunity an option?
    Ilesanmi OS; Akande A; Afolabi AA
    Pan Afr Med J; 2020; 35(Suppl 2):103. PubMed ID: 33282058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications.
    Jung J
    J Korean Med Sci; 2021 Feb; 36(7):e59. PubMed ID: 33619920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Epidemic Preventive Policies and Hospital Strategies in Combating COVID-19 Outbreak in Taiwan.
    Tan TW; Tan HL; Chang MN; Lin WS; Chang CM
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33810438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence.
    Setti L; Passarini F; De Gennaro G; Barbieri P; Pallavicini A; Ruscio M; Piscitelli P; Colao A; Miani A
    Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32344853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological characteristics of the first 100 cases of coronavirus disease 2019 (COVID-19) in Hong Kong Special Administrative Region, China, a city with a stringent containment policy.
    Lai CKC; Ng RWY; Wong MCS; Chong KC; Yeoh YK; Chen Z; Chan PKS
    Int J Epidemiol; 2020 Aug; 49(4):1096-1105. PubMed ID: 32601677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Review of the concept of herd immunity, in the context of COVID-19 epidemic and the development of vaccines].
    Canals L M
    Rev Chilena Infectol; 2021 Aug; 38(4):495-499. PubMed ID: 34652394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public Engagement and Government Responsiveness in the Communications About COVID-19 During the Early Epidemic Stage in China: Infodemiology Study on Social Media Data.
    Liao Q; Yuan J; Dong M; Yang L; Fielding R; Lam WWT
    J Med Internet Res; 2020 May; 22(5):e18796. PubMed ID: 32412414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Incidence of SARS-CoV-2 Within Incarcerated Populations and Possible Implications for Herd Immunity.
    Xu J; Lim A; Rutherford G
    J Correct Health Care; 2022 Apr; 28(2):71-74. PubMed ID: 35143356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
    Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
    Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 outbreak in a state prison: a case study on the implementation of key public health recommendations for containment and prevention.
    Duarte C; Cameron DB; Kwan AT; Bertozzi SM; Williams BA; McCoy SI
    BMC Public Health; 2022 May; 22(1):977. PubMed ID: 35568894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to the COVID-19 Epidemic: The Chinese Experience and Implications for Other Countries.
    Liu W; Yue XG; Tchounwou PB
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32235413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to Understand Herd Immunity in the Context of COVID-19.
    Dong M; He F; Deng Y
    Viral Immunol; 2021 Apr; 34(3):174-181. PubMed ID: 33351708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study.
    Zou Z; Fairley CK; Shen M; Scott N; Xu X; Li Z; Li R; Zhuang G; Zhang L
    Int J Infect Dis; 2022 Feb; 115():154-165. PubMed ID: 34800688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can Africa achieve herd immunity?
    Lucero-Prisno DE; Ogunkola IO; Esu EB; Adebisi YA; Lin X; Li H
    Glob Health Res Policy; 2021 Dec; 6(1):46. PubMed ID: 34852844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.